COMMUNIQUÉS West-GlobeNewswire
-
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
28/07/2026 -
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
28/07/2026 -
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
28/07/2026 -
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
28/07/2026 -
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
28/07/2026 -
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
28/07/2026 -
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
28/07/2026 -
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship
28/07/2026 -
Cato Healthcare Supply Strengthens Executive Leadership Team
28/07/2026 -
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
28/07/2026 -
Grief goes global on screen as first-of-its-kind festival receives over 500 films from six continents
28/07/2026 -
Starget Pharma Expands Scientific Advisory Board with Appointment of Two Global Leaders in Radiopharmaceutical Therapy
28/07/2026 -
ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial
28/07/2026 -
Transactions in connection with share buy-back program
28/07/2026 -
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
28/07/2026 -
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
28/07/2026 -
Aqua free Supports Drinking Water Project in Tanzania
28/07/2026 -
Aqua free soutient un projet d’accès à l’eau potable en Tanzanie
28/07/2026 -
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
28/07/2026
Pages